Fits and starts in developing a revolutionary new inhaled insulin have meant that Al Mann’s MannKind has had more than its fair share of pops and drops over the past few years. MannKind won FDA approval for Afrezza last summer and announced its commercial launch earlier this month . The news has investors wondering if now is a good time […]
CORAL GABLES, FL / ACCESSWIRE / February 11, 2015 / It’s been a long and rough road for a push toward universal legalization of marijuana in the US. Since the early beginnings in California many decades ago with medical marijuana to the latest trail being blazed from states like Colorado, Oregon, Washington, and Alaska, this has certainly become a growth […]
Leading Health Care Stock for Small-Cap Stars is Athersys Inc. (ATHX) for January 20
By iCELL News on January 22, 2015 · Investing
Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com’s Small-Cap Stars, our proprietary list of small-cap companies with characteristics we’ve found […]
Biotech stocks are among the market’s riskiest, but investors willing to accept the potential for pipeline failure might consider owning these five small-cap biotech stocks in 2015. All five have intriguing therapies in late-stage clinical trials, and three have high-profile big-cap partners.Source: Flickr user Carlos Gracia1. Proven performerInsys Therapeutics is already rewarding shareholders with rapid sales growth and profitability, but […]
Year end is coming up quickly, and that has investors pouring over portfolios, dissecting financial reports, and considering names to own heading into 2015. ;With that in mind, read on to learn why ;I think these three biotech stocks may prove worthy enough of investor wish-lists next month.Source: Cubist Pharmaceuticals1. Treating hospital infectionsOn December 21, the FDA will make a […]
